Éric Lingueglia

Title: Éric Lingueglia: Innovator in Analgesic Peptides

Introduction

Éric Lingueglia is a prominent inventor based in Nice, France. He has made significant contributions to the field of pain management through his innovative research on peptides. With a total of 2 patents, his work focuses on developing novel analgesic compounds derived from natural sources.

Latest Patents

Lingueglia's latest patents include groundbreaking discoveries related to peptides that have analgesic effects and inhibit Acid Sensing Ion Channels (ASIC). One of his notable inventions involves isolated peptides from snake venom that induce analgesia and inhibit ASIC channels. This invention encompasses the polynucleotides encoding these peptides, as well as pharmaceutical compositions, host cells, and vectors that incorporate them. Additionally, he has developed a method for treating pain or itching using the APETx2 peptide toxin, which blocks ASIC3 cationic channels derived from sea anemones. This peptide is particularly effective in alleviating pain associated with inflammation and various painful conditions linked to tissue acidosis.

Career Highlights

Throughout his career, Éric Lingueglia has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and Université Nice Sophia Antipolis. His research has significantly advanced the understanding of pain mechanisms and the development of new therapeutic strategies.

Collaborations

Lingueglia has collaborated with notable colleagues, including Michel Lazdunski and Sylvie Diochot, contributing to a rich exchange of ideas and expertise in the field of pain research.

Conclusion

Éric Lingueglia's innovative work in the development of analgesic peptides showcases his commitment to advancing medical science and improving pain management. His contributions are paving the way for new therapeutic options in the treatment of pain.